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ABSTRACT 
Automatically locating named entities in natural language text – 
named entity recognition – is an important task in the biomedical 
domain. Many named entity mentions are ambiguous between 
several bioconcept types, however, causing text spans to be 
annotated as more than one type when simultaneously recognizing 
multiple entity types. The straightforward solution is a rule-based 
approach applying a priority order based on the precision of each 
entity tagger (from highest to lowest). While this method is 
straightforward and useful, imprecise disambiguation remains a 
significant source of error. We address this issue by generating a 
partially labeled corpus of ambiguous concept mentions. We first 
collect named entity mentions from multiple human-curated 
databases (e.g. CTDbase, gene2pubmed), then correlate them with 
the text mined span from PubTator to provide the context where 
the mention appears. Our corpus contains more than 3 million 
concept mentions that ambiguous between one or more concept 
types in PubTator (≈ 3% of all mentions). We approached this 
task as a classification problem and developed a deep learning-
based method which uses the semantics of the span being 
classified and the surrounding words to identify the most likely 
bioconcept type. More specifically, we develop a convolutional 
neural network (CNN) and along short-term memory (LSTM) 
network to respectively handle the semantic syntax features, then 
concatenate these within a fully connected layer for final 
classification. The priority ordering rule-based approach 
demonstrated F1-scores of 71.29% (micro-averaged) and 41.19% 
(macro-averaged), while the new disambiguation method 
demonstrated F1-scores of 91.94% (micro-averaged) and 85.42% 
(macro-averaged), a very substantial increase. 
KEYWORDS 
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1  Introduction 
Mentions of concepts such as genes and diseases in the 
biomedical literature play a key role in knowledge integration and 
personalized medicine. Due to the rapid growth of the literature, 
automatically recognizing bioconcept mentions has become a very 
important task. The text mining tasks of named-entity recognition 
(NER) and normalization have been widely studied for a variety 
of bioconcept types, including genes/proteins [1-3], diseases [4, 
5], chemicals [5-7], species [8, 9], sequence variations [10-13], 
and cell lines [14]. Most of these methods achieved over 80% of 
F1-score, a level of performance sufficient to allow the creation of 
several online systems [15-18] integrating the annotations from 
multiple NER taggers to support various downstream text mining 
tasks. 
A variety of ambiguity issues accompany NER methods, making 
automated NER methods difficult. Among these issues are 
abbreviation ambiguity (e.g., “BD” can be Binswanger's disease 
and Behçet's disease) and term variants (e.g., erbb2 is also known 
as NEU; NGL; HER2; TKR1; CD340; HER-2; MLN 19; HER-
2/neu). These have been explored well in previous work, such as 
Ab3P [19] for abbreviation ambiguity. 
However, a specific term ambiguity issue that is rarely discussed 
is that many recognized mentions may be ambiguous among 
multiple bioconcept types. For instance, “CO2” is sometimes used 
as an abbreviation of the gene/protein “complement C2” 
(EntrezGene:717) but used for the chemical term “carbon 
dioxide” (MESH: D002245) in other articles. Previous work in 
PubTator [18], which integrates annotations from several NER 
taggers across articles in PubMed, used a straightforward rule-
based approach for disambiguating bioconcept types. This 
approach is a priority order based on the precision of the NER 
taggers, ordered from the highest to the lowest. Normally, the 
tagger with the higher precision produces annotations with higher 
confidence. While helpful, many false positives and false 
negatives remain after using this approach. For instance, mutation 
annotations are prioritized ahead of all other bioconcepts, 
however we find false positives of mutations are often cell lines 
(e.g., A2780S in PMID: 25026335) or chemicals (e.g., C3368-A 
in PMID:7767952).   
Unlike general named entity normalization studies which map the 
name entities found by NER to their corresponding concept 
identifiers [20-22], the task of biomedical concept disambiguation 
(BD) is to recognize the corresponding bioconcept type from a list 
of candidates (e.g., AP2 can be a name of gene (EntrezGene: 
2167), chemical (MeSH:C523965) or cell-line). In other words, 
BD is a task for optimizing the performance of named-entity 
recognition and normalization. Most NER corpora are created 
  
using a small number of bioconcept types to limit the annotation 
work required, limiting their usefulness for BD. For example, the 
GENETAG corpus [23] annotates only genes, proteins, and the 
BC5CDR corpus [24] annotates only chemicals and diseases. Due 
to the lack of a comprehensive training corpus for BD, it is 
difficult to develop a model to recognize the corresponding 
bioconcept types of highly ambiguous mentions (e.g., 
abbreviations). 
In response, we firstly generated a partially labeled corpus of 
ambiguous concept mentions by utilizing multiple human-curated 
databases and text mined spans of PubTator, and then applied 
convolutional neural networks (CNN) [25] and long short-term 
memory (LSTM) [26] to develop a classification method for this 
task. Our method analyses the semantic and syntactic logic of 
both the target mention and the words surrounding the target to 
identify the most likely bioconcept types for the mentions. 
2  Benchmark Corpus 
Table 1. The list of repositories we collected for building a 
comprehensive corpus 
Repository Gene Disease Chemical Species Variant 
Cell 
Line 
gene2pubmed  √      
GeneRIF [30] √      
gene_interactions 
[30] 
√     
 
CTDbase [29] √ √ √    
RGD [31] √ √  √   
BioGRID [32] √   √   
NCBI  
Taxonomy [33] 
   √  
 
MeSH [34] √ √ √ √  √ 
ZFIN [35] √   √   
ClinVar [36]     √  
dbGAP [37]     √  
dbSNP [38]     √  
GWAS [39] √ √   √  
HPRD [40] √ √     
Cellosaurus [41]      √ 
 
While the data used for method development and training is 
usually prepared manually, creating new manual annotation is 
highly labor intensive. In this work we instead collected the 
necessary biomedical named-entity data from multiple sources 
already annotated manually, such as MeSH [27], gene2pubmed 
[28] and CTDbase [29] as shown in Table 1. These repositories 
associate PubMed identifiers (PMIDs) with a concept or database 
identifier (accession ID), such as <PMID:10021333, 
GeneID:41066> from gene2pubmed 
(ftp://ftp.ncbi.nlm.nih.gov/gene/DATA/gene2pubmed.gz).  
We have observed that the correct concept type for most 
ambiguous mentions can be identified by reviewing the context. 
However, none of the repositories record the location of the 
mentions corresponding to the concepts they annotate (i.e., offset 
and span). The absence of mention location significantly limits the 
immediate utility of the repository annotations for disambiguation. 
Unlike the manually annotated repositories, PubTator [18] 
provides the spans of the mentions which were automatically 
extracted by machine learning-based taggers (GNormPlus [3] for 
genes, tmVar [12, 13] for variants, SR4GN [9] for species, 
DNorm [4] for diseases and tmChem [6] for chemicals). Cell lines 
are another common concept type that are frequently ambiguous. 
In this work, we rebuilt an NER model in TaggerOne [5] to 
recognize cell line mentions. The model is trained and evaluated 
by the released corpus of BioCreative Bio-ID task [42] and 
obtained 83.10% of F1-score. These taggers were previously 
evaluated and achieved 80-90% of F1-scores in normalization 
results. To obtain the spans of the concepts in the repositories, we 
utilized the spans recorded in PubTator. For example, while 
MeSH associates PMID:23262785 with “Breast Neoplasms” 
(MeSH:D001943), the mention recognized by DNorm for 
MeSH:D001943 is “breast cancer.” We therefore consider the 
span of the mention “breast cancer” as the span for MeSH 
ID:D001943 in PMID:23262785 (as shown in Figure 1). 
 
  
Figure 1. An example of the confirmed MESH annotation with 
span 
 
Figure 2 shows the number of annotations in all the collected 
repositories and in PubTator respectively. The overlapping area 
represents the repository annotations that can be paired with spans 
in PubTator.  For example, <PMID:10022874, NCBIGene:1977, 
Spans: “Eukaryotic translation initiation factor 4E”&”eIF4E“>. 
Correlating annotations from the repositories and PubTator 
resulted in nearly 24 million repository records (25.6%) from 13 
million articles being associated with spans from PubTator. 
We further separated the records into individual spans. For 
example, <PMID:10022874, NCBIGene:1977, Spans: 
“Eukaryotic translation initiation factor 4E”&”eIF4E“>  can be 
separated into two individual records <PMID:10022874, 
NCBIGene:1977, Spans: “Eukaryotic translation initiation factor 
4E”> and <PMID:10022874, NCBIGene:1977, Spans:”eIF4E“>. 
We obtained a total of 33,173,360 records with individual spans. 
To focus on the subset of records representing ambiguous 
annotations, we filtered the spans to only retain spans tagged with 
multiple entity types, such as “XPID” in PMID: 23378296, which 
is recognized as both a disease and a gene in PubTator (“XPID” is 
manually annotated as a gene in MeSH). After filtering, 219,247 
annotations remain. 
PMID 23262785
Accession id MESH:D001943
Span breast cancer
  
 
Figure 2. The annotations in repositories and the annotations in 
PubTator (with spans).  
 
Table 2. The number of annotations <PMID, Concept ID, Spans> 
in repositories.  
Bioconcept 
# of 
annotations 
with spans 
from multiple 
repositories 
Individual 
mentions 
with spans 
found in 
PubTator 
Ambiguous 
mentions 
with spans 
Gene 2,076,650 3,093,005 79,418 
Disease 9,683,680 14,356,863 27,591 
Species 4,677,865 6,575,790 65,113 
Chemical 7,431,195 9,014,513 46,400 
Variation 92,411 108,019 262 
Cell line 20,76,650 25,170 463 
Total 23,986,864 33,173,360 219,247 
Articles 
in Total 
13,203,651 184,671 
 
Table 3. The number of annotations in the training and test sets, 
for each concept type. 
Bioconcept 
Random sampling Independent sampling  
Training set Test set Training set Test set 
Gene 63,521 20,952 58,466 15,897 
Disease 22,065 2,158 25,433 5,526 
Species  52,175 12,479 52,634 12,938 
Chemical 37,041 10,120 36,280 9,359 
Variation 210 62 200 52 
Cell line 385 74 389 78 
Total 175,397 45,845 173,402 43,850 
 
We created two versions of the training and test sets, using 
different sampling strategies, as shown in Table 3. We first 
selected 20% of the ambiguous mentions with spans for testing 
and the other 80% for training/validation (random sampling). 
However, under random sampling most of the mentions in the test 
set would also appear in the training set if the test mentions. To 
sufficiently reflect real-world performance, we prepared another 
training/test set split (independent sampling), where the test set 
only contains mentions that do not appear in the training set, 
though they were selected randomly otherwise. 
3  Method 
As illustrated in Figure 3, we first collected the manual 
annotations from various repositories (in Figure 3a) and 
associated them with the text mined mention spans from PubTator 
(in Figure 3b), and further separated the corpus into training and 
test sets (in Figure 3c). We applied the training set for the 
development of the classifier and the test set for performance 
evaluation (in Figure 3d). 
 
 
Figure 3. Method overview. 
 
As shown in Figure 4, we used the surrounding words before and 
after the target mention within the context window (size = 10). 
For an example in the first sentence of PMID:10022874 
“Eukaryotic translation initiation factor 4E (eIF4E) binds to the 
mRNA 5' cap and brings the mRNA into a complex with other 
protein synthesis initiation factors and ribosomes.”, the context 
words before the target mention “eIF4E”, are “Eukaryotic 
translation initiation factor 4E eIF4E” and the context words after 
it are “eIF4E binds to the mRNA 5 cap and brings the RNA”. 
Generally, LSTM is more effective than CNN on sequential input, 
 
93,711,518 records
19,717,175 PMIDs
Repositories
104,046,605 records
29,691,822 PMIDs
23,986,864 records | 13,203,651 PMIDs
Record : <PMID, Concept ID, Spans>
(a) Collecting annotations 
from repositories
(b) Filling the spans 
by 
(c) Preparing 
the corpus 
Test set
PMID Type Identifier Repositories
10021770 Gene 35587 Gene2pubmed
10022083 Gene 775 Gene2pubmed
10022118 Gene 1026 gene2pubmed|gene_interactions|HARD
10022118 Gene 836 gene_interactions|gene2pubmed|HARD
… … … …
Training set
(d) Training & Evaluation
CNN
PMID: 10022874 
Spans: eIF4E
GeneLSTM
  
 
Figure 4. The system overview that includes three major layers: word embedding layer, CNN+LSTM layer and concatenation layer. 
 
because LSTMs model sequential data directly by considering the 
input features of the previous token, while CNNs only consider 
the input features of the current token. Thus, we used LSTM for 
the surrounding words features and CNN for semantic features. 
To emphasize the importance of the target mention, we applied 
two LSTM models with opposite directions to the forward and 
backward strings. The last states of the two LSTM models are 
passed to the final fully connected layer for predicting the concept 
type of the mention. 
Table 4. The list of the semantic and word features 
Feature types Features 
Semantic features 
Concept types detected by NER 
taggers 
Concept identifiers detected by NER 
taggers 
The concept type of the full name 
detected by NER taggers 
The concept identifier of the full 
name detected by NER taggers 
Word features 
Prefix (Length = 1~3) 
Suffix (Length = 1~3) 
 
We further applied a CNN model on the semantic and word 
features collected by the rules list in Table 4. Word features 
includes the prefixes and the suffixes of all tokens of the target 
mention. Semantic features include those generated by the NER 
taggers, including concept type, identifiers of the target mentions 
and its correspond full name recognized by Ab3P [19]. Our 
method uses word embeddings to translate word to vectors, which 
generalizes well for biomedical text. The embedding layer of the 
word and semantic features use one-hot embeddings. 
Due to the lack of the variant and cell line records, two types are 
weakened significantly. To increase the number of training 
records of the two types, we repeatedly loaded the records of the 
two types in training sets for 10 times. We implemented the 
CNN/LSTM model using Keras and the TensorFlow library. 
Table 5 summarizes the hyperparameters we applied in our 
network. Our word embedding was the 200-dimensional vector 
which used the word2vec [43] skip-gram implementation on all 
PubMed abstracts and Wikipedia pages. We also applied dropout 
to reduce the effect of overfitting. 
Table 5. The parameters of the CNN model 
Hyper-parameter Value 
Embedding dimension 
Word embedding 200 
Ono-hot embedding 200 
Convolutional layer 1 
(Con1D1) 
Number of filters 200 
Number of kernels 5 
Max pooling size  5 
Dropout rate 0.2 
Convolutional layer 2 
(Con1D2) 
Number of filters 1000 
Number of kernels 5 
Global Max pooling 
LSTM layer 
Number of units 128 
Dropout rate 0.2 
Recurrent dropout 0.2 
Concatenate layer 
Number of units 1256 
Activation Relu 
Fully connected layer 
Number of units 5 
Activation Softmax 
 
3.1 Baseline methods 
…
…
Word embedding
Forward
surrounding
words
Fully connected layer
output
One-hot embedding
Backward
surrounding
words
Semantic 
and word 
features
CNN+LSTM layer
LSTM
LSTM
LSTM
LSTM
LSTM
LSTM
LSTM
LSTM
…
…
…
Con1D1
Max Pooling
+ Dropout
…
… …
Con1D2
Global 
Max Pooling
  
We applied three additional methods for comparison: a rule-based 
method used in the original version of PubTator, maximum 
entropy classification (MaxEnt) [44] and BioBERT [45]. The 
rule-based method is a priority order based on the precision of 
each concept tagger, which is mutation > species > gene > 
chemical > disease > cell line. Secondly, we applied MaxEnt and 
to handle this task as a multiple classification problem. The 
MaxEnt has been widely used to deal with multi-type text 
classification problems in past decades and obtained comparable 
performance. We also applied BioBERT, which is a BERT model 
retrained on the entire PubMed/PMC and has obtained significant 
improvements on named-entity recognition, relation extraction, 
and question answering tasks. We converted the task to a sentence 
classification problem for BERT and all the contextual and 
semantic features are arranged as a sentence input. We also built a 
model which using a CNN layer for surrounding words and 
semantic features to determine how the LSTM helps the 
performance. 
4  Result 
4.1  Evaluation metrics 
We used the F1-score to evaluate the performance of the methods. 
The precision (P) represents the percentage of records correctly 
predicted divided by the total number of predictions. The recall 
(R) represents the percentage of records correctly predicted 
divided by the total number of records. Given the precision and 
recall, F1-score can be calculated as (P×R×2)÷(P+R). Given the 
lower number of variant and cell line type mentions in the test set, 
we also calculated the macro-averaged P, R, and F1-score, to give 
equal weight to each type. Macro-averaging is to average the P, R, 
and F1-score in all concept types. 
4.2  Evaluation 
Table 6. Performance on the benchmark corpus 
 Random sampling Independent sampling 
Micro 
F1-score 
Macro 
F1-score 
Micro 
F1-score 
Macro 
F1-score 
CNN+LSTM 93.56% 92.55% 91.94% 85.42% 
CNN only 93.34% 91.09% 91.78% 84.88% 
BioBERT 91.36% 88.26% 89.31% 82.22% 
MaxEnt 92.38% 87.69% 89.03% 82.44% 
Rule-based 68.99% 41.34% 71.29% 41.19% 
In our experiments, the performance of all the machine learning-
based (ML) methods on the randomly selected set provided 
excellent performance – F1-scores of over 90% –in both micro 
and macro averages. The performance dropped slightly, by 2% 
micro F1-score and 7% of macro F1-score, on the independent 
sampling set, indicating that the ML methods are robust in 
handling the unknown mentions. In addition, using the LSTM 
layer for surrounding words features slightly outperforms the 
model using CNN layers for all the features. Overall, our method 
presents the highest performance in both the random and 
independent sampling sets and can significantly improve the 
quality of PubTator ambiguous annotations (~25% improvement 
on micro F1-score and 40-50% improvement on macro F1-score). 
Furthermore, we separated the concept types to see the individual 
performance. Four concepts (i.e., species, mutation, chemical and 
gene) present higher performance than the overall macro-averaged 
F1-score, but disease and cell line types both present lower 
performances. The reason of the lower recall of cell line may due 
to the insufficient training data for the cell line type, which is less 
than 1% of the other types. The majority of the errors for cell line 
mentions are incorrectly predicting genes or chemicals, because 
chemicals and genes in the training set are frequently recognized 
by cell line tagger incorrectly. Disease scored the lowest 
precision, because many of the human disease names are confused 
with disease-causing viruses or bacteria (species names). More 
discussions of these points are in the error analysis. 
Table 7. Performances of individual concepts of the CNN+LSTM 
method in independent test set 
Concept type Precision Recall F1-score 
Disease 71.37% 71.21% 71.29% 
Species 99.60% 94.06% 96.75% 
Mutation 93.10% 87.10% 90.00% 
Cell line 93.75% 60.81% 73.77% 
Chemical 92.79% 83.85% 88.10% 
Gene 88.77% 96.74% 92.59% 
Micro average 91.93% 91.94% 91.94% 
Macro average 89.90% 82.30% 85.42% 
4.3 Error analysis 
Table 8. Bioconcept disambiguation error types in test set 
Description # % 
Conflict concepts are correct 143 72% 
One concept is a substring and associate 
with the other 
31 16% 
Abbreviation is not the same concept 
type to the full name 
15 8% 
Others 11 3% 
Total reviewed 200 100% 
To understand the causes of errors made by our method, we 
manually reviewed the incorrectly classified examples from the 
independent set made by the model which presented the best 
micro F1-score (91.93%), and further classified 200 randomly 
selected errors into several categories. In our observation, the 
most frequent overlapping types are species and disease. For 
example, “African Horse Sickness virus” is a name of species, but 
it can be also the name of an infectious disease. However, the 
repositories only one of the types were annotated in the 
repositories (i.e. either species or disease). In the other case, one 
concept is a substring of the other concept and is strongly 
associated with it, such as the gene name “breast cancer 2”, which 
includes the disease name “breast cancer” as a substring. The 
other frequent errors are due to conflicts between the abbreviation 
and its full name. For example, “Alkaptonuria” is a disease, but 
the abbreviation AKU is also associated with the gene that causes 
  
Alkaptonuria. In such cases, the classifiers are very easily 
confused. 
5  Conclusion 
Bioconcept disambiguation is an important task in the field of 
biomedical text mining. Our previous bioconcept tagging work 
found more than 3 million ambiguous concept mentions in 
PubMed and 17 million ambiguous concept mentions in PMC full 
text. In this study, we presented a deep learning-based method to 
address the task of bioconcept disambiguation, applying CNNs 
and LSTMs to respectively capture the semantic and syntactic 
features. To reduce the effort required to manually curate a 
benchmark set, we proposed a method to generate partially 
labeled data by gathering manual annotations from multiple 
existing repositories, then integrating them with the spans of 
PubTator annotations. The rule-based priority ordering approach 
demonstrated an F1-score of 71.29% on this dataset, while our 
proposed disambiguation method demonstrated an F1-score of 
91.94%, a very substantial improvement.  
There are two primary use cases for this work. One is to optimize 
the performance on ambiguous annotations when using several 
taggers to identify multiple concept types. For example, this 
method significantly improves the NER performance of our 
recently published text mining system PubTator Central [46]. The 
other primary use case is as a post-processing tool for a single 
NER tagger (e.g., TaggerOne), to improve the performance on the 
desired entity types by filtering predicted mentions more likely to 
be another type (false positives).  
An obvious limitation of this work is the relative lack of the 
ambiguous spans that could be collected form the existing 
repositories for cell lines (only 463 annotations available) and 
variants (only 262 annotations available). In the future, we intend 
to increase the number of annotations available for cell lines and 
variants through manual curation. 
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